InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Smith Julie, 董事. Officer active across 2 companies, notably Exelixis, INC.. Aggregated, 9 reports have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €531k. Activity tracked since 27 May 2021. The latest transaction was disclosed on 27 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Smith Julie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
8,367 股0Common StockSEC:0000939767-26-000080:0
42,422 股@ US$18.1936.4% 占其流量Common StockSEC:0000939767-26-000029:0
9,812 股0Common StockSEC:0000939767-25-000086:0
31,167 股@ US$20.5053.4% 占其流量Common StockSEC:0000939767-25-000045:0
4,682 股0Common StockSEC:0000939767-24-000129:0
10,015 股0Common StockSEC:0000939767-24-000094:0
27,280 股@ US$21.1246.6% 占其流量Common StockSEC:0000939767-24-000077:0
16,424 股0Common StockSEC:0000939767-21-000058:0
64,179 股Common StockSEC:0001140361-16-051872:0
9 条申报中的 9 条
About Smith Julie
Julie Smith serves as a Director at Exelixis, Inc. As a board member, she participates in overseeing the company's activities and shaping its strategy. Julie brings valuable experience in the biopharmaceutical sector, contributing to innovation and competitiveness at Exelixis. Her role is essential in ensuring that decisions made align with best governance practices.
